Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres

被引:53
作者
Choi, Y
Kim, SY
Kim, SH
Lee, KS
Kim, C
Byun, Y
机构
[1] Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangju 500712, South Korea
[2] Univ Ulsan, Coll Med, Dept Otolaryngol, Seoul 138736, South Korea
[3] Samsung Med Ctr, Dept Clin Pathol, Seoul 135710, South Korea
[4] Inha Univ, Sch Chem Sci & Engn, Inchon 402751, South Korea
关键词
all-trans-retinoic acid; biodegradable microspheres; polyethylene glycol-poly(L-lactide) diblock copolymer; poly(L-lactide)/polyethylene glycol-poly(L-lactide) blending;
D O I
10.1016/S0378-5173(00)00676-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
All-trans-retinoic acid (atRA) has been proved to be effective against several malignancies in human clinical trials. However, in many patients who were treated with atRA, the cancer relapsed after a brief remission. One reason for such relapse is that atRA is metabolized by specific P450s that are induced in the liver during prolonged atRA treatments. In order to overcome such a drawback of atRA, we prepared biodegradable microspheres to provide continuous release of atRA for a long period of time. These biodegradable microspheres were prepared by poly(L-lactide) (PLLA) and polyethylene glycol (PEG)-PLLA diblock copolymers (PLE) in various blending ratios to control the release rate of atRA. As the PLE content in microsphere was increased, the density of the hydrophilic PEG block of PLE on microsphere surfaces increased and the microspheres were dispersed well in PBS without any surfactants. Various release patterns of atRA were obtained according to PLE and atRA contents in the microspheres. Especially. the pseudo-zero-order release profiles were observed for 5 weeks when the contents of PLE and atRA in the microspheres were above 4 wt.%. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:67 / 81
页数:15
相关论文
共 38 条
  • [1] ACHKAR CC, 1994, DRUG METAB DISPOS, V22, P451
  • [2] ADAMSON PC, 1994, SEMIN HEMATOL, V31, P14
  • [3] ADAMSON PC, 1993, P AM ASSOC CANC RES, V34, P1265
  • [4] pH and osmotic pressure inside biodegradable microspheres during erosion
    Brunner, A
    Mäder, K
    Göpferich, A
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (06) : 847 - 853
  • [5] CHOI Y, IN PRESS BIOMATERIAL
  • [6] Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid
    Estey, E
    Thall, PF
    Mehta, K
    Rosenblum, M
    Brewer, T
    Simmons, V
    Cabanillas, F
    Kurzrock, R
    LopezBerestein, G
    [J]. BLOOD, 1996, 87 (09) : 3650 - 3654
  • [7] Gliadin nanoparticles for the controlled release of all-trans-retinoic acid
    Ezpeleta, I
    Irache, JM
    Stainmesse, S
    Chabenat, C
    Gueguen, J
    Popineau, Y
    Orecchioni, AM
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 131 (02) : 191 - 200
  • [8] THE RETINOIC ACID SYNDROME IN ACUTE PROMYELOCYTIC LEUKEMIA
    FRANKEL, SR
    EARDLEY, A
    LAUWERS, G
    WEISS, M
    WARRELL, RP
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (04) : 292 - 296
  • [9] Giannini F, 1997, INT J CANCER, V70, P194
  • [10] TRETINOIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND USE IN THE MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    GILLIS, JC
    GOA, KL
    [J]. DRUGS, 1995, 50 (05) : 897 - 923